Our Mission
The Powering Precision Health movement represents the intersection of new technological capabilities & the latest medical research. It transforms how we approach healthcare, from scrambling to cure diseases after the fact, to preventing & detecting diseases long before symptoms are present, when disease is most curable.

Challenge and Opportunities for Blood Tests for Alzheimer's, MS, Parkinson's and ALS
16:54
Challenge and Opportunities for Blood Tests for Alzheimer's, MS, Parkinson's and ALS
Powering Precision Health Today with Guest Irina Banzola
20:08
Powering Precision Health Today with Guest Irina Banzola
Personalizing Checkpoint Inhibitor-Based Cancer Immunotherapy
14:24
Personalizing Checkpoint Inhibitor-Based Cancer Immunotherapy
Multi-Omic Molecular Tumor Boards
15:39
Multi-Omic Molecular Tumor Boards
The Role of Multi-Omic Profiling for Treatment Selection in Metastatic Breast Cancer
17:09
The Role of Multi-Omic Profiling for Treatment Selection in Metastatic Breast Cancer
Predictive Biomarkers to Guide Anti-Angiogenic Therapy: The Search Continues
16:56
Predictive Biomarkers to Guide Anti-Angiogenic Therapy: The Search Continues
Biomarkers - Ideal, Reality and Future
15:32
Biomarkers - Ideal, Reality and Future
The 2019 Powering Precision Health Summit in Barcelona
5:39
The 2019 Powering Precision Health Summit in Barcelona
Neurofilament Light Chain: Real World Applicability in Multiple Sclerosis
17:00
Neurofilament Light Chain: Real World Applicability in Multiple Sclerosis
Endophenotypes of Traumatic Brain Injury: What to Know For the Next Generation of Clinical Trials
18:19
Endophenotypes of Traumatic Brain Injury: What to Know For the Next Generation of Clinical Trials
Alzheimer's Disease and Markers of Neuroinflammation
15:02
Alzheimer's Disease and Markers of Neuroinflammation
pTau in Plasma- the next NfL?
8:41
pTau in Plasma- the next NfL?
Kevin Hrusovsky PPH 2019 Keynote
35:58
Kevin Hrusovsky PPH 2019 Keynote
Enabling Clinical Trials of Disease-Modifying Therapies for Huntington's Disease
16:30
Enabling Clinical Trials of Disease-Modifying Therapies for Huntington's Disease
Accelerating Biomarker Development Through Novel Collaborations
17:25
Accelerating Biomarker Development Through Novel Collaborations
Plasma Amyloid, GFAP, Nf-L and pTau as predictors of Alzheimer's Pathology
9:39
Plasma Amyloid, GFAP, Nf-L and pTau as predictors of Alzheimer's Pathology
Care Management Platform for Multiple Sclerosis
18:14
Care Management Platform for Multiple Sclerosis
Neurofilament Light Chain: Hot Topics
15:26
Neurofilament Light Chain: Hot Topics
Growing Market, Changing Society and Future Medical Needs
18:58
Growing Market, Changing Society and Future Medical Needs
Neurofilament Light Chain: A New Candidate Biomarker in hATTR Amyloidosis
11:34
Neurofilament Light Chain: A New Candidate Biomarker in hATTR Amyloidosis
Development of IVD Assays for a Global Market
17:32
Development of IVD Assays for a Global Market
Type 1 Interferon Signalling Pathway
11:02
Type 1 Interferon Signalling Pathway
Cytokines and Chemokines in the Cross-Talk Between Cancer Cells and the Immune System
14:33
Cytokines and Chemokines in the Cross-Talk Between Cancer Cells and the Immune System
Using Ultrasensitive Single and Multiplex Biomarkers for Precision Medicine
18:20
Using Ultrasensitive Single and Multiplex Biomarkers for Precision Medicine
Industry Perspectives on Context of Use and Biomarker Assays
13:08
Industry Perspectives on Context of Use and Biomarker Assays
Neurology Innovator Panel PPH 2016
1:23:36
Neurology Innovator Panel PPH 2016
Powering Precision Health Summit 2018
5:26
Powering Precision Health Summit 2018
PPH16 Kevin Hrusovsky
40:53
PPH16 Kevin Hrusovsky
PPH16 John Yan, Takeda Pharmaceutical Co
22:20
PPH16 John Yan, Takeda Pharmaceutical Co
What is Powering Precision Health?
7:57
What is Powering Precision Health?